Clinical Trial Update: Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir combination with Ribavirin for chronic Hepatitis C Virus infection genotype 4…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir

Snippet

Sponsor: Beni-Suef University | Conditions: Chronic Hepatitis C Virus Infection | Phase 1, Phase 2 | Status: COMPLETED